The prevalence and prognostic value of KRAS co‐mutation subtypes in Chinese advanced non‐small cell lung cancer patients

por Cai, Dongjing, Hu, Chengping, Li, Li, Deng, Shichao, Yang, Jing, Han‐Zhang, Han, Li, Min
Publicado 2019

An EGFR-Amplified Cervical Squamous Cell Carcinoma Patient with Pulmonary Metastasis Benefits from Afatinib: A Case Report

por Chen, Qian, Huang, Yihua, Shao, Lin, Han-Zhang, Han, Yang, Fan, Wang, Yang, Liu, Jing, Gan, Jiadi
Publicado 2020

Efficacy of afatinib in a HER2 amplification-positive endometrioid adenocarcinoma patient– a case report

por Zhou, Li, Ren, Yifeng, Wang, Xia, Miao, Dongliu, Lizaso, Analyn, Li, Haiyan, Han-Zhang, Han, Qian, Jun, Yang, Hui
Publicado 2019

Perioperative Circulating Tumor DNA in Colorectal Liver Metastases: Concordance with Metastatic Tissue and Predictive Value for Tumor Burden and Prognosis

por He, Yiping, Ma, Xiaoji, Chen, Ke, Liu, Fangqi, Cai, Sanjun, Han-Zhang, Han, Hou, Ting, Xiang, Jianxing, Peng, Junjie
Publicado 2020

Clinicopathologic features and genomic analysis of pulmonary blastomatoid carcinosarcoma

por Zhao, Jikai, Xiang, Chan, Zhao, Ruiying, Guo, Ping, Zheng, Jingjing, Han-Zhang, Han, Yu, Keke, Zhang, Jie, Han, Yuchen
Publicado 2020

The association between BRAF mutation class and clinical features in BRAF-mutant Chinese non-small cell lung cancer patients

por Lin, Quan, Zhang, Haoran, Ding, Huaxin, Qian, Jun, Lizaso, Analyn, Lin, Jing, Han-Zhang, Han, Xiang, Jianxing, Li, Yuping, Zhu, Hong
Publicado 2019

Somatic POLE exonuclease domain mutations elicit enhanced intratumoral immune responses in stage II colorectal cancer

por Mo, Shaobo, Ma, Xiaoji, Li, Yaqi, Zhang, Long, Hou, Ting, Han-Zhang, Han, Qian, Juanjuan, Cai, Sanjun, Huang, Dan, Peng, Junjie
Publicado 2020

Targeted Sequencing Analysis of Predominant Histological Subtypes in Resected Stage I Invasive Lung Adenocarcinoma

por Li, Yan, Tan, Yan, Hu, Song, Xie, Jun, Yan, Zhantao, Zhang, Xian, Zong, Yun, Han-Zhang, Han, Li, Qing, Li, Chong
Publicado 2021

IBI362 (LY3305677), a weekly-dose GLP-1 and glucagon receptor dual agonist, in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple ascending dose...

por Ji, Linong, Jiang, Hongwei, An, Pei, Deng, Huan, Liu, Meng, Li, Li, Feng, Liqi, Song, Baili, Han-Zhang, Han, Ma, Qingyang, Qian, Lei
Publicado 2021

Comparison of genomic landscapes of large cell neuroendocrine carcinoma, small cell lung carcinoma, and large cell carcinoma

por Zhou, Zhen, Zhu, Lei, Niu, Xiaomin, Shen, Shengping, Zhao, Yi, Zhang, Jie, Ye, Junyi, Han‐Zhang, Han, Liu, Junjun, Liu, Chenglin, Lu, Shun
Publicado 2019

Distinctive genomic characteristics in POLE/POLD1-mutant cancers can potentially predict beneficial clinical outcomes in patients who receive immune checkpoint inhibitor

por He, Junjun, Ouyang, Wei, Zhao, Wugan, Shao, Lin, Li, Bing, Liu, Bihao, Wang, Dejuan, Han-Zhang, Han, Zhang, Zhou, Shao, Liang, Li, Wencai
Publicado 2021

Efficacy of erlotinib as neoadjuvant regimen in EGFR-mutant locally advanced non-small cell lung cancer patients

por Xiong, Liwen, Lou, Yuqing, Bai, Hao, Li, Rong, Xia, Jinjing, Fang, Wentao, Zhang, Jie, Han-Zhang, Han, Lizaso, Analyn, Li, Bing, Gu, Aiqin, Han, Baohui
Publicado 2019

Characterization of Frequently Mutated Cancer Genes and Tumor Mutation Burden in Chinese Breast Cancer

por Xiao, Weikai, Zhang, Guochun, Chen, Bo, Chen, Xiaoqing, Wen, Lingzhu, Lai, Jianguo, Li, Xuerui, Li, Min, Liu, Hao, Liu, Jing, Han-Zhang, Han, Lizaso, Analyn, Liao, Ning
Publicado 2021

Mutational Landscape of PI3K-AKT-mTOR Pathway in Breast Cancer: Implications for Targeted Therapeutics

por Xiao, Weikai, Zhang, Guochun, Chen, Bo, Chen, Xiaoqing, Wen, Lingzhu, Lai, Jianguo, Li, Xuerui, Li, Min, Liu, Hao, Liu, Jing, Han-Zhang, Han, Lizaso, Analyn, Liao, Ning
Publicado 2021

A phase 1b randomised controlled trial of a glucagon-like peptide-1 and glucagon receptor dual agonist IBI362 (LY3305677) in Chinese patients with type 2 diabetes

por Jiang, Hongwei, Pang, Shuguang, Zhang, Yawei, Yu, Ting, Liu, Meng, Deng, Huan, Li, Li, Feng, Liqi, Song, Baili, Han-Zhang, Han, Ma, Qingyang, Qian, Lei, Yang, Wenying
Publicado 2022

Mutations in exon 8 of TP53 are associated with shorter survival in patients with advanced lung cancer

por Liu, Yutao, Xu, Fang, Wang, Yubo, Wu, Qingchen, Wang, Buhai, Yao, Yanwen, Zhang, Yu, Han-Zhang, Han, Ye, Junyi, Zhang, Lu, Mao, Xinru, Zhang, Zhe, Liu, Jing, Zhu, Liangjun, Guo, Renhua
Publicado 2019

A comprehensive pan-cancer study of fibroblast growth factor receptor aberrations in Chinese cancer patients

por Sun, Yi, Li, Gao, Zhu, Wei, He, Qiuyan, Liu, Yongchang, Chen, Xianshan, Liu, Juan, Lin, Jing, Han-Zhang, Han, Yang, Zheng, Lizaso, Analyn, Xiang, Jianxing, Mao, Xinru, Liu, Hao, Gao, Yang
Publicado 2020

EGFR Thr790Leu as a Potential Resistance Mechanism to First-Generation EGFR Tyrosine Kinase Inhibitor May Respond to Osimertinib in Patients With Lung Adenocarcinoma

por Xiang, Chan, Zhang, Wei, Xiong, Li-Wen, Cai, Xu-Wei, Teng, Hao-Hua, Zhao, Rui-Ying, Shang, Zhan-Xian, Han-Zhang, Han, Zhang, Lu, Yan, Li, Chen, Zhi-Qiu, Han, Yu-Chen
Publicado 2021

Germline Profiling and Molecular Characterization of Early Onset Metastatic Colorectal Cancer

por Xu, Ting, Zhang, Yinjie, Zhang, Jing, Qi, Changsong, Liu, Dan, Wang, Zhenghang, Li, Yanyan, Ji, Congcong, Li, Jian, Lin, Xuan, Hou, Ting, Liu, Hao, Zhang, Lu, Han-Zhang, Han, Shen, Lin, Wang, Xicheng
Publicado 2020

FXR1 regulates transcription and is required for growth of human cancer cells with TP53/FXR2 homozygous deletion

por Fan, Yichao, Yue, Jiao, Xiao, Mengtao, Han-Zhang, Han, Wang, Yao Vickie, Ma, Chun, Deng, Zhilin, Li, Yingxiang, Yu, Yanyan, Wang, Xinghao, Niu, Shen, Hua, Youjia, Weng, Zhiping, Atadja, Peter, Li, En, Xiang, Bin
Publicado 2017